|
Variables
|
Exercise group
|
Dopamine agonists group
|
Placebo group
|
|---|
|
STS- 5 (sec)
| | | |
|
Baseline
|
10.12±2.56
|
8.89±0.74
|
9.69±0.46
|
|
6-m post
|
8.24±2.34†
|
8.48±1.72
|
8.81±0.66
|
|
Δ Change
|
−1.75±2.32
|
- 0.41±1.63
|
- 0.88±0.76
|
|
95% CI of Δ change
|
−3.03 to −0.47
|
−1.91 to 1.09
|
−1.58 to −0.18
|
|
STS-30 (rep)
| | | |
|
Baseline
|
14.73±4.00
|
14.83±2.13
|
14.75±0.9
|
|
6-m post
|
17.84± 4.68†
|
14.50±2.58
|
17.25±3.2
|
|
Δ Change
|
2.96±4.87
|
- 0.33±2.33
|
2.50±2.51
|
|
95% CI of Δ change
|
5.65 to 0.27
|
−0.63 to −0.03
|
4.81 to −0.19
|
|
STS-60 (rep)
| | | |
|
Baseline
|
27.95±8.38
|
26.60±3.64
|
30.0±3.16
|
|
6-m post
|
32.50±9.34
|
27.40±7.40
|
32.0±5.35
|
|
Δ Change
|
4.26±8.23
|
0.80±4.65
|
2.00±3.26
|
|
95% CI of Δ change
|
8.77 to −0.25
|
5.09 to −3.49
|
5.0 to −1.0
|
|
Normal Walk (sec)
| | | |
|
Baseline
|
6.09±1.24
|
5.69±1.53
|
5.30±1.06
|
|
6-m post
|
5.81±1.49
|
6.14±1.63
|
5.38±1.09
|
|
Δ Change
|
−0.42±1.36
|
0.44±1.46
|
0.07±0.27
|
|
95% CI of Δ change
|
−1.17 to 0.33
|
1.78 to −0.90
|
0.31 to −0.17
|
|
Fast Walk (sec)
| | | |
|
Baseline
|
3.86±0.66
|
3.57±0.40
|
3.77±0.47
|
|
6-m post
|
3.65±0.75
|
3.56±0.40
|
3.57±0.41
|
|
Δ Change
|
−0.28±0.65
|
- 0.01±0.19
|
- 0.19±0.40
|
|
95% CI of Δ change
|
−0.63 to 0.07
|
−0.18 to 0.16
|
−0.55 to 0.17
|
|
NSRI test (sec)
| | | |
|
Baseline
|
84.46±21.35
|
70.10±20.46
|
52.48±14.24
|
|
6-m post
|
75.02±26.60†
|
67.68±20.78
|
53.44±17.13
|
|
Δ Change
|
−9.25±13.41
|
−2.41±6.52
|
0.96±4.01
|
|
95% CI of Δ change
|
−16.6 to −1.85
|
−8.41 to 3.59
|
4.65 to −2.73
|
- All data are mean ± SD. Abbreviations: STS-5 Sit-to- stand test 5-repetitions, STS-60 Sit-to- stand test 60 seconds, STS-30 Repetitions’ measurement at 30 seconds as part of the STS-60 test, NSRI North staffordshire royal infirmary test.
-
†Significantly different from the respective baseline value.
